 | • レポートコード：QYR2104Z4672 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肺炎検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、分析装置）、用途別市場規模（病院、診療所、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺炎検査の市場動向 ・企業の競争状況、市場シェア ・肺炎検査の種類別市場規模（消耗品、分析装置） ・肺炎検査の用途別市場規模（病院、診療所、医療センター、その他） ・肺炎検査の北米市場規模2016-2027（アメリカ、カナダ） ・肺炎検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺炎検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺炎検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺炎検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Molecular、Fast-track diagnostics、Becton, Dickenson and Company (BD)、Roche Molecular Diagnostics、Thermo Fisher Scientific、AdvanDx、Abbott、Beckman Coulter、Bio-Rad、Cepheid、Concile、Diamedix、DiaSorin、Eiken Chemical） ・結論 |
Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection.
The rising popularity of point-of-care (POC) testing as one of the primary growth factors for this market.
Market Analysis and Insights: Global Pneumonia Testing Market
The global Pneumonia Testing market size is projected to reach US$ 1469.7 million by 2026, from US$ 889.1 million in 2019, at a CAGR of 7.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pneumonia Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pneumonia Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pneumonia Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pneumonia Testing market.
Global Pneumonia Testing Scope and Market Size
Pneumonia Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Consumables
Analyzers
Segment by Application
Hospital
Clinic
Medical Center
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Molecular
Fast-track diagnostics
Becton, Dickenson and Company (BD)
Roche Molecular Diagnostics
Thermo Fisher Scientific
AdvanDx
Abbott
Beckman Coulter
Bio-Rad
Roche Molecular Diagnostics
Thermo Fisher Scientific
Diamedix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Consumables
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global Pneumonia Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Testing Market Perspective (2016-2027)
2.2 Pneumonia Testing Growth Trends by Regions
2.2.1 Pneumonia Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pneumonia Testing Historic Market Share by Regions (2016-2021)
2.2.3 Pneumonia Testing Forecasted Market Size by Regions (2022-2027)
2.3 Pneumonia Testing Industry Dynamic
2.3.1 Pneumonia Testing Market Trends
2.3.2 Pneumonia Testing Market Drivers
2.3.3 Pneumonia Testing Market Challenges
2.3.4 Pneumonia Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Testing Players by Revenue
3.1.1 Global Top Pneumonia Testing Players by Revenue (2016-2021)
3.1.2 Global Pneumonia Testing Revenue Market Share by Players (2016-2021)
3.2 Global Pneumonia Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumonia Testing Revenue
3.4 Global Pneumonia Testing Market Concentration Ratio
3.4.1 Global Pneumonia Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Testing Revenue in 2020
3.5 Pneumonia Testing Key Players Head office and Area Served
3.6 Key Players Pneumonia Testing Product Solution and Service
3.7 Date of Enter into Pneumonia Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumonia Testing Breakdown Data by Type
4.1 Global Pneumonia Testing Historic Market Size by Type (2016-2021)
4.2 Global Pneumonia Testing Forecasted Market Size by Type (2022-2027)
5 Pneumonia Testing Breakdown Data by Application
5.1 Global Pneumonia Testing Historic Market Size by Application (2016-2021)
5.2 Global Pneumonia Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pneumonia Testing Market Size (2016-2027)
6.2 North America Pneumonia Testing Market Size by Type
6.2.1 North America Pneumonia Testing Market Size by Type (2016-2021)
6.2.2 North America Pneumonia Testing Market Size by Type (2022-2027)
6.2.3 North America Pneumonia Testing Market Size by Type (2016-2027)
6.3 North America Pneumonia Testing Market Size by Application
6.3.1 North America Pneumonia Testing Market Size by Application (2016-2021)
6.3.2 North America Pneumonia Testing Market Size by Application (2022-2027)
6.3.3 North America Pneumonia Testing Market Size by Application (2016-2027)
6.4 North America Pneumonia Testing Market Size by Country
6.4.1 North America Pneumonia Testing Market Size by Country (2016-2021)
6.4.2 North America Pneumonia Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pneumonia Testing Market Size (2016-2027)
7.2 Europe Pneumonia Testing Market Size by Type
7.2.1 Europe Pneumonia Testing Market Size by Type (2016-2021)
7.2.2 Europe Pneumonia Testing Market Size by Type (2022-2027)
7.2.3 Europe Pneumonia Testing Market Size by Type (2016-2027)
7.3 Europe Pneumonia Testing Market Size by Application
7.3.1 Europe Pneumonia Testing Market Size by Application (2016-2021)
7.3.2 Europe Pneumonia Testing Market Size by Application (2022-2027)
7.3.3 Europe Pneumonia Testing Market Size by Application (2016-2027)
7.4 Europe Pneumonia Testing Market Size by Country
7.4.1 Europe Pneumonia Testing Market Size by Country (2016-2021)
7.4.2 Europe Pneumonia Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Testing Market Size (2016-2027)
8.2 Asia-Pacific Pneumonia Testing Market Size by Type
8.2.1 Asia-Pacific Pneumonia Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pneumonia Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pneumonia Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Pneumonia Testing Market Size by Application
8.3.1 Asia-Pacific Pneumonia Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pneumonia Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pneumonia Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Pneumonia Testing Market Size by Region
8.4.1 Asia-Pacific Pneumonia Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pneumonia Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pneumonia Testing Market Size (2016-2027)
9.2 Latin America Pneumonia Testing Market Size by Type
9.2.1 Latin America Pneumonia Testing Market Size by Type (2016-2021)
9.2.2 Latin America Pneumonia Testing Market Size by Type (2022-2027)
9.2.3 Latin America Pneumonia Testing Market Size by Type (2016-2027)
9.3 Latin America Pneumonia Testing Market Size by Application
9.3.1 Latin America Pneumonia Testing Market Size by Application (2016-2021)
9.3.2 Latin America Pneumonia Testing Market Size by Application (2022-2027)
9.3.3 Latin America Pneumonia Testing Market Size by Application (2016-2027)
9.4 Latin America Pneumonia Testing Market Size by Country
9.4.1 Latin America Pneumonia Testing Market Size by Country (2016-2021)
9.4.2 Latin America Pneumonia Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Testing Market Size (2016-2027)
10.2 Middle East & Africa Pneumonia Testing Market Size by Type
10.2.1 Middle East & Africa Pneumonia Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pneumonia Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pneumonia Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Pneumonia Testing Market Size by Application
10.3.1 Middle East & Africa Pneumonia Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pneumonia Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pneumonia Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Pneumonia Testing Market Size by Country
10.4.1 Middle East & Africa Pneumonia Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pneumonia Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Molecular
11.1.1 Abbott Molecular Company Details
11.1.2 Abbott Molecular Business Overview
11.1.3 Abbott Molecular Pneumonia Testing Introduction
11.1.4 Abbott Molecular Revenue in Pneumonia Testing Business (2016-2021)
11.1.5 Abbott Molecular Recent Development
11.2 Fast-track diagnostics
11.2.1 Fast-track diagnostics Company Details
11.2.2 Fast-track diagnostics Business Overview
11.2.3 Fast-track diagnostics Pneumonia Testing Introduction
11.2.4 Fast-track diagnostics Revenue in Pneumonia Testing Business (2016-2021)
11.2.5 Fast-track diagnostics Recent Development
11.3 Becton, Dickenson and Company (BD)
11.3.1 Becton, Dickenson and Company (BD) Company Details
11.3.2 Becton, Dickenson and Company (BD) Business Overview
11.3.3 Becton, Dickenson and Company (BD) Pneumonia Testing Introduction
11.3.4 Becton, Dickenson and Company (BD) Revenue in Pneumonia Testing Business (2016-2021)
11.3.5 Becton, Dickenson and Company (BD) Recent Development
11.4 Roche Molecular Diagnostics
11.4.1 Roche Molecular Diagnostics Company Details
11.4.2 Roche Molecular Diagnostics Business Overview
11.4.3 Roche Molecular Diagnostics Pneumonia Testing Introduction
11.4.4 Roche Molecular Diagnostics Revenue in Pneumonia Testing Business (2016-2021)
11.4.5 Roche Molecular Diagnostics Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Pneumonia Testing Introduction
11.5.4 Thermo Fisher Scientific Revenue in Pneumonia Testing Business (2016-2021)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 AdvanDx
11.6.1 AdvanDx Company Details
11.6.2 AdvanDx Business Overview
11.6.3 AdvanDx Pneumonia Testing Introduction
11.6.4 AdvanDx Revenue in Pneumonia Testing Business (2016-2021)
11.6.5 AdvanDx Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Pneumonia Testing Introduction
11.7.4 Abbott Revenue in Pneumonia Testing Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Pneumonia Testing Introduction
11.8.4 Beckman Coulter Revenue in Pneumonia Testing Business (2016-2021)
11.8.5 Beckman Coulter Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Pneumonia Testing Introduction
11.9.4 Bio-Rad Revenue in Pneumonia Testing Business (2016-2021)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Pneumonia Testing Introduction
11.10.4 Cepheid Revenue in Pneumonia Testing Business (2016-2021)
11.10.5 Cepheid Recent Development
11.11 Concile
11.11.1 Concile Company Details
11.11.2 Concile Business Overview
11.11.3 Concile Pneumonia Testing Introduction
11.11.4 Concile Revenue in Pneumonia Testing Business (2016-2021)
11.11.5 Concile Recent Development
11.12 Diamedix
11.12.1 Diamedix Company Details
11.12.2 Diamedix Business Overview
11.12.3 Diamedix Pneumonia Testing Introduction
11.12.4 Diamedix Revenue in Pneumonia Testing Business (2016-2021)
11.12.5 Diamedix Recent Development
11.13 DiaSorin
11.13.1 DiaSorin Company Details
11.13.2 DiaSorin Business Overview
11.13.3 DiaSorin Pneumonia Testing Introduction
11.13.4 DiaSorin Revenue in Pneumonia Testing Business (2016-2021)
11.13.5 DiaSorin Recent Development
11.14 Eiken Chemical
11.14.1 Eiken Chemical Company Details
11.14.2 Eiken Chemical Business Overview
11.14.3 Eiken Chemical Pneumonia Testing Introduction
11.14.4 Eiken Chemical Revenue in Pneumonia Testing Business (2016-2021)
11.14.5 Eiken Chemical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pneumonia Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Consumables
Table 3. Key Players of Analyzers
Table 4. Global Pneumonia Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pneumonia Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pneumonia Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pneumonia Testing Market Share by Regions (2016-2021)
Table 8. Global Pneumonia Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pneumonia Testing Market Share by Regions (2022-2027)
Table 10. Pneumonia Testing Market Trends
Table 11. Pneumonia Testing Market Drivers
Table 12. Pneumonia Testing Market Challenges
Table 13. Pneumonia Testing Market Restraints
Table 14. Global Pneumonia Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pneumonia Testing Market Share by Players (2016-2021)
Table 16. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Testing as of 2020)
Table 17. Ranking of Global Top Pneumonia Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pneumonia Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pneumonia Testing Product Solution and Service
Table 21. Date of Enter into Pneumonia Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pneumonia Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pneumonia Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Pneumonia Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pneumonia Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pneumonia Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pneumonia Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Pneumonia Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pneumonia Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pneumonia Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pneumonia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pneumonia Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pneumonia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pneumonia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pneumonia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pneumonia Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pneumonia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pneumonia Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pneumonia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pneumonia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pneumonia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pneumonia Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pneumonia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pneumonia Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pneumonia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pneumonia Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pneumonia Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pneumonia Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pneumonia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pneumonia Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pneumonia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pneumonia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pneumonia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pneumonia Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pneumonia Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pneumonia Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pneumonia Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pneumonia Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pneumonia Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Molecular Company Details
Table 62. Abbott Molecular Business Overview
Table 63. Abbott Molecular Pneumonia Testing Product
Table 64. Abbott Molecular Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 65. Abbott Molecular Recent Development
Table 66. Fast-track diagnostics Company Details
Table 67. Fast-track diagnostics Business Overview
Table 68. Fast-track diagnostics Pneumonia Testing Product
Table 69. Fast-track diagnostics Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 70. Fast-track diagnostics Recent Development
Table 71. Becton, Dickenson and Company (BD) Company Details
Table 72. Becton, Dickenson and Company (BD) Business Overview
Table 73. Becton, Dickenson and Company (BD) Pneumonia Testing Product
Table 74. Becton, Dickenson and Company (BD) Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 75. Becton, Dickenson and Company (BD) Recent Development
Table 76. Roche Molecular Diagnostics Company Details
Table 77. Roche Molecular Diagnostics Business Overview
Table 78. Roche Molecular Diagnostics Pneumonia Testing Product
Table 79. Roche Molecular Diagnostics Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 80. Roche Molecular Diagnostics Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Pneumonia Testing Product
Table 84. Thermo Fisher Scientific Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. AdvanDx Company Details
Table 87. AdvanDx Business Overview
Table 88. AdvanDx Pneumonia Testing Product
Table 89. AdvanDx Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 90. AdvanDx Recent Development
Table 91. Abbott Company Details
Table 92. Abbott Business Overview
Table 93. Abbott Pneumonia Testing Product
Table 94. Abbott Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 95. Abbott Recent Development
Table 96. Beckman Coulter Company Details
Table 97. Beckman Coulter Business Overview
Table 98. Beckman Coulter Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 99. Beckman Coulter Recent Development
Table 100. Bio-Rad Company Details
Table 101. Bio-Rad Business Overview
Table 102. Bio-Rad Pneumonia Testing Product
Table 103. Bio-Rad Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 104. Bio-Rad Recent Development
Table 105. Cepheid Company Details
Table 106. Cepheid Business Overview
Table 107. Cepheid Pneumonia Testing Product
Table 108. Cepheid Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 109. Cepheid Recent Development
Table 110. Concile Company Details
Table 111. Concile Business Overview
Table 112. Concile Pneumonia Testing Product
Table 113. Concile Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 114. Concile Recent Development
Table 115. Diamedix Company Details
Table 116. Diamedix Business Overview
Table 117. Diamedix Pneumonia Testing Product
Table 118. Diamedix Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 119. Diamedix Recent Development
Table 120. DiaSorin Company Details
Table 121. DiaSorin Business Overview
Table 122. DiaSorin Pneumonia Testing Product
Table 123. DiaSorin Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 124. DiaSorin Recent Development
Table 125. Eiken Chemical Company Details
Table 126. Eiken Chemical Business Overview
Table 127. Eiken Chemical Pneumonia Testing Product
Table 128. Eiken Chemical Revenue in Pneumonia Testing Business (2016-2021) & (US$ Million)
Table 129. Eiken Chemical Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Testing Market Share by Type: 2020 VS 2027
Figure 2. Consumables Features
Figure 3. Analyzers Features
Figure 4. Global Pneumonia Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Medical Center Case Studies
Figure 8. Other Case Studies
Figure 9. Pneumonia Testing Report Years Considered
Figure 10. Global Pneumonia Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pneumonia Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pneumonia Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Pneumonia Testing Market Share by Regions (2022-2027)
Figure 14. Global Pneumonia Testing Market Share by Players in 2020
Figure 15. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pneumonia Testing Revenue in 2020
Figure 17. Global Pneumonia Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Pneumonia Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pneumonia Testing Market Share by Type (2016-2027)
Figure 21. North America Pneumonia Testing Market Share by Application (2016-2027)
Figure 22. North America Pneumonia Testing Market Share by Country (2016-2027)
Figure 23. United States Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pneumonia Testing Market Share by Type (2016-2027)
Figure 27. Europe Pneumonia Testing Market Share by Application (2016-2027)
Figure 28. Europe Pneumonia Testing Market Share by Country (2016-2027)
Figure 29. Germany Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pneumonia Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pneumonia Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pneumonia Testing Market Share by Region (2016-2027)
Figure 39. China Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pneumonia Testing Market Share by Type (2016-2027)
Figure 47. Latin America Pneumonia Testing Market Share by Application (2016-2027)
Figure 48. Latin America Pneumonia Testing Market Share by Country (2016-2027)
Figure 49. Mexico Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pneumonia Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pneumonia Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pneumonia Testing Market Share by Country (2016-2027)
Figure 55. Turkey Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pneumonia Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Molecular Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 59. Fast-track diagnostics Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 60. Becton, Dickenson and Company (BD) Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 61. Roche Molecular Diagnostics Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 63. AdvanDx Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 65. Beckman Coulter Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 66. Bio-Rad Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 67. Cepheid Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 68. Concile Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 69. Diamedix Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 70. DiaSorin Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 71. Eiken Chemical Revenue Growth Rate in Pneumonia Testing Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の院内肺炎予防市場規模・現状・予測（2021年-2027年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…- 世界の肺炎市場規模・現状・予測（2021年-2027年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…
- 世界の肺炎治療薬市場規模・現状・予測（2021年-2027年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…
- 世界の人工呼吸器関連肺炎（VAP）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Market The global Ventilator Associated Pneumonia (VAP) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の肺炎診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pneumonia Diagnostic Market The global Pneumonia Diagnostic market size is projected to reach US$ 636.1 million by 2026, from US$ 446.3 million in 2019, at a CAGR of 5.1% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the r…